Case 3:17-cv-05659-WHA Document 556-1 Filed 06/25/19 Page 1 of 5
`
`Exhibit 1
`
`REDACTED VERSION OF
`DOCUMENT SOUGHT TO BE SEALED
`
`

`

`Case 3:17-cv-05659-WHA Document 556-1 Filed 06/25/19 Page 2 of 5
`
`From:
`Sent:
`To:
`Cc:
`
`Subject:
`
`Glucoft, Josh <JGlucoft@irell.com>
`Monday, June 17, 2019 5:36 PM
`Williams, Daniel
`Andre, Paul; Kobialka, Lisa; Hannah, James; Kastens, Kris; Carson, Rebecca; Heinrich,
`Alan; Holland, Eileen; Isaac, Shawana; Kagan, Jonathan; Manzano, Jim; Mittleman, Harry;
`Quarnstrom, Brian; Theilacker, Leah; Wang, Kevin; #Juniper/Finjan [Int]
`[EXTERNAL] RE: Depositions and 30(b)(6) topics
`
`Dan,
`
`Juniper designates Mr. Frank Jas as its 30(b)(6) witness on the following topics:
`
`Juniper’s acquisition of Cyphort Inc., including reasoning for the acquisition and the terms of the acquisition
` The nature of any alleged non-infringing alternatives or design-arounds to the inventions of the Asserted Patents,
`including the cost of implementing such alternatives or design-arounds and how such costs were calculated
` Any technology license agreements (including hardware or software) or patent license agreements Juniper is
`aware of related to any component or technology of the Accused Instrumentalities, including the dates of such
`agreements, the length of the negotiations of the agreements, the terms of the agreements, the subject product(s)
`or technolog(ies) of the agreements, how any license fee or royalties were determined or calculated, whether
`alternate license fee or payment structures were considered during negotiations, and names and titles of the
`individuals who were involved in negotiating the agreements.
`
`
`
`
`
`
`
`
`
`
`
`
`From: Williams, Daniel <DDWilliams@KRAMERLEVIN.com>  
`Sent: Monday, June 17, 2019 10:52 AM 
`To: Glucoft, Josh <JGlucoft@irell.com> 
`Cc: ~Andre, Paul <pandre@kramerlevin.com>; ~Kobialka, Lisa <lkobialka@kramerlevin.com>; ~Hannah, James 
`<jhannah@kramerlevin.com>; ~Kastens, Kristopher <kkastens@kramerlevin.com>; Carson, Rebecca 
`<RCarson@irell.com>; Heinrich, Alan <AHeinrich@irell.com>; Holland, Eileen <EHolland@irell.com>; Isaac, Shawana 
`<SIsaac@irell.com>; Kagan, Jonathan <JKagan@irell.com>; Manzano, Jim <JManzano@irell.com>; Mittleman, Harry 
`<HMittleman@irell.com>; Quarnstrom, Brian <BQuarnstrom@irell.com>; Theilacker, Leah <LTheilacker@irell.com>; 
`Wang, Kevin <kwang@irell.com>; #Juniper/Finjan [Int] <Juniper‐Finjan@irell.com> 
`Subject: RE: Depositions and 30(b)(6) topics 
` 
`Josh, 
` 
`Please advise on the remaining 30(b)(6) topics from our June 6 email below. 
` 
`Regards, 
`Dan 
` 
` 
`
`
`
`Daniel Williams
`Associate
`
`1
`
`

`

`Case 3:17-cv-05659-WHA Document 556-1 Filed 06/25/19 Page 3 of 5
`
`
`
`Kramer Levin Naftalis & Frankel LLP
`990 Marsh Road, Menlo Park, California 94025
`T 650.752.1735 F 650.752.1800
`
`This communication (including any attachments) is intended solely for the recipient(s) named above and may contain information that is
`confidential, privileged or legally protected. Any unauthorized use or dissemination of this communication is strictly prohibited. If you have received
`this communication in error, please immediately notify the sender by return e-mail message and delete all copies of the original communication.
`Thank you for your cooperation.
`
`
`
`From: Williams, Daniel <DDWilliams@KRAMERLEVIN.com>  
`Sent: Friday, June 14, 2019 4:39 PM 
`To: Glucoft, Josh <JGlucoft@irell.com> 
`Cc: Andre, Paul <PAndre@KRAMERLEVIN.com>; Kobialka, Lisa <LKobialka@KRAMERLEVIN.com>; Hannah, James 
`<JHannah@KRAMERLEVIN.com>; Kastens, Kris <KKastens@KRAMERLEVIN.com>; Carson, Rebecca <RCarson@irell.com>; 
`Heinrich, Alan <AHeinrich@irell.com>; Holland, Eileen <EHolland@irell.com>; Isaac, Shawana <SIsaac@irell.com>; 
`Kagan, Jonathan <JKagan@irell.com>; Manzano, Jim <JManzano@irell.com>; Mittleman, Harry 
`<HMittleman@irell.com>; Quarnstrom, Brian <BQuarnstrom@irell.com>; Theilacker, Leah <LTheilacker@irell.com>; 
`Wang, Kevin <kwang@irell.com>; #Juniper/Finjan [Int] <Juniper‐Finjan@irell.com> 
`Subject: RE: Depositions and 30(b)(6) topics 
` 
`Josh, 
` 
`Finjan agrees to withdraw its requests for Messrs. Kuznetsov and Marcellin given Juniper’s confirmation that they are 
`not calling them at trial and will not use them in support of any expert report. 
` 
`We confirm the deposition of Mr. Jas on July 2.  We’ll start at 8AM to make sure we have sufficient time on the record.  
` 
`Finjan is still looking into whether Mr. Touboul can make it to the U.S. for his deposition. 
` 
`Finjan’s position is that a 30(b)(6) depositions of under 3.5 hours does not count as a deposition and any 30(b)(6) 
`deposition of over 3.5 hours counts as a deposition. 
` 
`Sincerely, 
`Dan 
` 
` 
`
`
`Daniel Williams
`Associate
`
`
`Kramer Levin Naftalis & Frankel LLP
`990 Marsh Road, Menlo Park, California 94025
`T 650.752.1735 F 650.752.1800
`
`This communication (including any attachments) is intended solely for the recipient(s) named above and may contain information that is
`confidential, privileged or legally protected. Any unauthorized use or dissemination of this communication is strictly prohibited. If you have received
`this communication in error, please immediately notify the sender by return e-mail message and delete all copies of the original communication.
`Thank you for your cooperation.
`
`
`
`From: Glucoft, Josh <JGlucoft@irell.com>  
`Sent: Thursday, June 13, 2019 10:14 AM 
`
`2
`
`

`

`Case 3:17-cv-05659-WHA Document 556-1 Filed 06/25/19 Page 4 of 5
`
`To: Williams, Daniel <DDWilliams@KRAMERLEVIN.com> 
`Cc: Andre, Paul <PAndre@KRAMERLEVIN.com>; Kobialka, Lisa <LKobialka@KRAMERLEVIN.com>; Hannah, James 
`<JHannah@KRAMERLEVIN.com>; Kastens, Kris <KKastens@KRAMERLEVIN.com>; Carson, Rebecca <RCarson@irell.com>; 
`Heinrich, Alan <AHeinrich@irell.com>; Holland, Eileen <EHolland@irell.com>; Isaac, Shawana <SIsaac@irell.com>; 
`Kagan, Jonathan <JKagan@irell.com>; Manzano, Jim <JManzano@irell.com>; Mittleman, Harry 
`<HMittleman@irell.com>; Quarnstrom, Brian <BQuarnstrom@irell.com>; Theilacker, Leah <LTheilacker@irell.com>; 
`Wang, Kevin <kwang@irell.com>; #Juniper/Finjan [Int] <Juniper‐Finjan@irell.com> 
`Subject: [EXTERNAL] RE: Depositions and 30(b)(6) topics 
` 
`Dan,
`
`
`With respect to Mr. Volodymyr Kuznetsov and Mr. Michael Marcellin, Juniper can confirm that they will not be testifying
`at trial, and thus does Juniper does not agree that there is good cause for Finjan to take their depositions.
`
`
`The deposition of Mr. Jas will take place on July 2 with a hard stop at 5 pm, however we are available to start a little
`earlier than 9 am if Finjan believes that is necessary.
`
`In view of Judge Hixson’s Order at Dkt. No. 518, please confirm whether Finjan intends to depose Mr. Touboul in the
`Northern District of California and please propose dates for his deposition.
`
`
`Lastly, please clarify whether Finjan believes that, in view of Judge Hixson’s Order at Dkt. No. 518, Finjan may take up
`to seven more Rule 30(b)(6) depositions so long as each such deposition is 3.5 hours or less.
`
`
`Regards,
`Josh
`  
`
` 
`From: Williams, Daniel <DDWilliams@KRAMERLEVIN.com>  
`Sent: Thursday, June 6, 2019 6:01 PM 
`To: Glucoft, Josh <JGlucoft@irell.com> 
`Cc: ~Andre, Paul <pandre@kramerlevin.com>; ~Kobialka, Lisa <lkobialka@kramerlevin.com>; ~Hannah, James 
`<jhannah@kramerlevin.com>; ~Kastens, Kristopher <kkastens@kramerlevin.com>; Carson, Rebecca 
`<RCarson@irell.com>; Heinrich, Alan <AHeinrich@irell.com>; Holland, Eileen <EHolland@irell.com>; Isaac, Shawana 
`<SIsaac@irell.com>; Kagan, Jonathan <JKagan@irell.com>; Manzano, Jim <JManzano@irell.com>; Mittleman, Harry 
`<HMittleman@irell.com>; Quarnstrom, Brian <BQuarnstrom@irell.com>; Theilacker, Leah <LTheilacker@irell.com>; 
`Wang, Kevin <kwang@irell.com>; #Juniper/Finjan [Int] <Juniper‐Finjan@irell.com> 
`Subject: Depositions and 30(b)(6) topics 
`
`  
`Counsel, 
`
`  
`As Judge Hixson has determined that Finjan has taken no more than 8 depositions, provide times for the deposition of 
`Mr. Jas.  Furthermore, provide a date for the already identified 30(b)(6) topic on revenue. 
`
`  
`Finjan will also take the deposition of the following Juniper employees currently listed on Juniper’s initial 
`disclosures:  Volodymyr Kuznetsov and Michael Marcellin.  Confirm that Juniper does not object to Finjan taking the 
`deposition of these employees based on the number of depositions taken by Finjan, as Juniper has more than 10 people 
`on its initial disclosures.  If Juniper refuses to make these employees available for deposition, provide times for a lead 
`counsel meet and confer on this. 
`
`  
`Finally, provide times that Juniper is available to meet and confer regarding scheduling depositions for the following 
`30(b)(6) Topics: 
`  
`
`
`
`Juniper’s acquisition of Cyphort Inc., including reasoning for the acquisition and the terms of the acquisition.  
`3
`
`

`

`Case 3:17-cv-05659-WHA Document 556-1 Filed 06/25/19 Page 5 of 5
`
` 
`
` 
`
` The nature of any alleged non‐infringing alternatives or design‐arounds to the inventions of the Asserted 
`Patents, including the cost of implementing such alternatives or design‐arounds and how such costs were 
`calculated. 
` Any technology license agreements (including hardware or software) or patent license agreements Juniper is 
`aware of related to any component or technology of the Accused Instrumentalities, including the dates of such 
`agreements, the length of the negotiations of the agreements, the terms of the agreements, the subject 
`product(s) or technolog(ies) of the agreements, how any license fee or royalties were determined or calculated, 
`whether alternate license fee or payment structures were considered during negotiations, and names and titles 
`of the individuals who were involved in negotiating the agreements. 
`Juniper’s sales and marketing strategies with respect to the Accused Instrumentalities, including bundling or 
`cross‐selling/upselling of any products with the Accused Instrumentalities, how Juniper conducts competitive 
`analysis, any surveys or studies concerning why customers purchase the Accused Instrumentalities, what 
`features are most used, how often features are used, and what drives sales of the Accused Instrumentalities.  
` 
`
`
`
`
`
`
`
`  
`
`Sincerely, 
`Dan 
`  
` 
`
`Daniel Williams 
`Associate 
`
` 
`Kramer Levin Naftalis & Frankel LLP 
`990 Marsh Road, Menlo Park, California 94025 
`T 650.752.1735 F 650.752.1800 
`ddwilliams@kramerlevin.com 
`
` 
`Bio 
`  
`This communication (including any attachments) is intended solely for the recipient(s) named above and may contain information that is
`confidential, privileged or legally protected. Any unauthorized use or dissemination of this communication is strictly prohibited. If you have received
`this communication in error, please immediately notify the sender by return e-mail message and delete all copies of the original communication.
`Thank you for your cooperation. 
`  
`
`
`
`PLEASE NOTE: This message, including any attachments, may include privileged, confidential and/or inside
`information. Any distribution or use of this communication by anyone other than the intended recipient(s) is
`strictly prohibited and may be unlawful. If you are not the intended recipient, please notify the sender by
`replying to this message and then delete it from your system. Thank you.
`
`4
`
`